Jain, Bhav http://orcid.org/0000-0003-2648-4894
Yamoah, Kosj http://orcid.org/0000-0001-9055-3538
Lathan, Christopher S.
Muralidhar, Vinayak
Mahal, Brandon A. http://orcid.org/0000-0001-5406-3232
Nguyen, Paul L.
Dee, Edward Christopher http://orcid.org/0000-0001-6119-0889
Funding for this research was provided by:
Prostate Cancer Foundation
American Society for Radiation Oncology
U.S. Department of Defense
University of Miami
U.S. Department of Health & Human Services | National Institutes of Health (R01-CA240582)
Bayer
Janssen Pharmaceuticals
Astellas Pharma US
Article History
Received: 15 August 2021
Revised: 11 November 2021
Accepted: 25 November 2021
First Online: 21 February 2022
Competing interests
: BAM receives funding from the Prostate Cancer Foundation and (PCF), the American Society for Radiation Oncology (ASTRO), the Department of Defense, and the Sylvester Comprehensive Cancer Center outside the submitted work. PLN reported receiving grants and personal fees from Bayer, Janssen, and Astellas and personal fees from Boston Scientific, Dendreon, Ferring, COTA, Blue Earth Diagnostics, and Augmenix outside the submitted work. VM received a grant from the Conquer Cancer Foundation outside the submitted work.